title: Control of intestinal stem cell fate: A novel approach to treating diabetes.
abstract: Targeting L-cell development and enrichment of incretin-secreting cells could potentially evolve as novel, effective therapeutics for diabetes.
authors.affiliation: Department of Diabetes, Endocrinology and Nutrition Graduate School of Medicine Kyoto University Kyoto Japan.
authors.forename: Shunsuke
authors.initials: S
authors.lastname: Yamane
authors.affiliation: Department of Diabetes, Endocrinology and Nutrition Graduate School of Medicine Kyoto University Kyoto Japan.
authors.forename: Nobuya
authors.initials: N
authors.lastname: Inagaki
mesh_terms: D000818:Animals; D019858:Enteroendocrine Cells / Q000502:physiology*; D006801:Humans; D054795:Incretins / Q000378:metabolism*; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D008297:Male
chemical_list: D054795:Incretins; D007328:Insulin